XML 20 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net sales $ 4,969 $ 5,526 $ 6,638
Cost of goods sold 3,902 4,463 4,667
Gross profit 1,067 1,063 1,971
Selling, general, and administrative expense 527 548 657
Research and development expense 93 80 82
Restructuring, asset-related, and other charges 80 87 49
Total other operating expenses 700 715 788
Equity in earnings of affiliates 23 29 43
Interest expense, net (210) (208) (195)
Loss on extinguishment of debt (22) 0 (38)
Other income (expense), net 21 (293) 162
Income (loss) before income taxes 179 (124) 1,155
(Benefit from) provision for income taxes (40) (72) 159
Net income (loss) 219 (52) 996
Less: Net income attributable to non-controlling interests 0 0 1
Net income (loss) attributable to Chemours $ 219 $ (52) $ 995
Per share data      
Basic earnings (loss) per share of common stock $ 1.33 $ (0.32) $ 5.62
Diluted earnings (loss) per share of common stock $ 1.32 $ (0.32) $ 5.45